
Loading, please wait...

Loading, please wait...

KIMS Hospitals in Bengaluru recently achieved a significant milestone by performing Karnataka's first NitrX knee replacement. Specifically, a surgical team led by Dr. Kumardev Arvind Rajamaniya treated a 65-year-old woman with advanced Grade 4 osteoarthritis. This specific procedure utilized a kinematic alignment instrument set to restore the joint's natural function. Consequently, the patient regained mobility quickly and left the hospital within three days. This development highlights the evolution of precision-driven orthopedic care in the region.
The NitrX knee replacement system stands out due to its unique medial pivot design. Unlike conventional implants, this design mimics natural knee biomechanics. It provides enhanced stability on the inner side while allowing fluid movement on the outer side. Furthermore, the implant features a specialized titanium niobium nitride coating. This coating significantly reduces metal reactivity, which benefits patients with metal sensitivities. Because the design is bone-conserving, it maintains consistent ligament tension throughout the range of motion. Therefore, patients often experience a more \"natural\" feeling in the knee joint post-surgery.
Surgeons chose kinematic alignment to recreate the patient's pre-arthritic knee anatomy accurately. This approach differs from standard mechanical alignment by focusing on the individual's unique bone structure. Therefore, the procedure offers a more personalized solution for severe osteoarthritis cases. Additionally, the single-radius design of the NitrX implant ensures stability during various activities, including climbing stairs. This initiative reflects the growing trend of evidence-based and patient-centric surgical practices in India. As a result, healthcare providers can now offer advanced options for those seeking to maintain high activity levels despite joint degeneration.
Q1: What are the primary benefits of the NitrX medial pivot design?
The medial pivot design mimics the natural movement of the human knee. It provides superior stability on the medial side and allows more natural sliding on the lateral side compared to traditional implants, enhancing mobility.
Q2: Who is the ideal candidate for the NitrX implant coating?
The titanium niobium nitride coating is particularly beneficial for patients with known metal sensitivities. This specialized layer offers low metal reactivity, reducing the risk of potential allergic responses to the orthopedic implant components.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


KIMS Hospitals performs Karnataka’s first NitrX medial pivot knee replacement using kinematic alignment for a 65-year-old patient with Grade 4 osteoarthriti...
7 months ago

A breakthrough study evaluated H5N1 transmission efficiency across mammalian isolates. Researchers discovered that human-derived D1.1 harboring the PB2 D701N mutation spread efficiently in ferrets, unlike strains carrying PB2 E627K. This finding highlights critical genetic markers for zoonotic surveillance.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today